Extremely active murine amyloid enhancing factor

Clinical and Experimental Rheumatology

Volumn 14, Issue 1, 1996, Pages 37-42

  Shtrasburg, S ^a   Livneh, A ^a   Gal, R ^b,c   Pras, M ^a  

^a HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

^b HASHARON HOSPITAL   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

amyloid A; amyloid enhancing factor; amyloidosis

Indexed keywords

AMYLOID ENHANCING FACTOR; UNCLASSIFIED DRUG;

AMYLOIDOSIS; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MOUSE; PRIORITY JOURNAL;

AMYLOID; AMYLOIDOSIS; ANIMALS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOPROTEINS; MALE; MICE; SPLENIC DISEASES;

EID: 0029882127     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. HUSEBEKK A, SKOGEN B, HUSBY G, MARHAUG G: Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol 1985; 21: 283-7.
2. TAPE C, TAN R, NESHEIM M, KISILEVSKY R: Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits. Scand J Immunol 1988; 28: 317-24.
3. YAKAR S, KAPLAN B, LIVNEH A, MARTIN B, MIURA K, ALI-KHAN Z, SHTRASBURG S, PRAS M: Direct evidence for SAA deposition in tissue during murine amyloidogenesis. Scand J Immunol 1994; 40: 653-8.
4. COHEN AS, SHIRAHAMA T: Animal model: spontaneous and induced amyloidosis. Am J Pathol 1972; 68: 441-4.
5. GRUYS E, SNEL FW: Animal models for reactive amyloidosis. Bailliere's Clin Rheumatol 1994; 8: 599-611.
6. RANLOV P: The adoptive transfer of experimental mouse amyloidosis by intravenous injection of spleen cell extracts from casein-treated syngeneic donor mice. Acta Pathol Microbiol Scand 1967; 70: 321-35.
7. JANIGAN DT, DRUET RL: Experimental murine amyloido-sis in X-irradiated recipients of spleen homogenates or serum from sensitized donors. Am J Pathol 1968; 52: 381-90.
8. SHIRAHAMA T, LAWLESS OJ, COHEN AS: Heterologous transfer of amyloid - human to mouse (33594). Proc Soc Exp Biol Med 1969; 130; 516-9.
9. AXERLAD M, KISILEVSKY R, BESWETHERICK S: Acceleration of amyloidosis by syngeneic spleen cells from normal donors. Am J Pathol 1975; 78: 277-84.
10. HOL PR, VAN ANDEL ACJ, VAN EDEREN AM, DRAAYER J, GRUYS E: Amyloid enhancing factor in hamster. Br J Exp Pathol 1985; 66: 689-97.
11. BALTZ ML, CASPI D, HIND CRK, FEINSTEIN A, PEPYS MB: Isolation and characterization of amyloid enhancing factor (AEF). In: GLENNER GG, OSSERMAN EF, BENDITT EP, CALKINS E, COHEN AS, AND ZUCKER-FRANKLIN D (Eds): Amyloidosis, NY & London, Plenum Press, 1986: 115-21.
12. VARGA J, FLINN MSM, SHIRAHAMA T, RODGERS OG, COHEN AS: The induction of accelerated murine amyloid with human splenic extract. Probable role of amyloid enhancing factor. Virchows Arch [B] 1986; 51: 177-85.
13. YOKOTA T, ISHIHARA T, KAWANO H, TAKAHASHI M, FUJINAGA Y, UCHINO F: Amyloid enhancing factor (AEF) in the aging mouse. Virchows Archiv A [Pathol Anat] 1989; 414: 511-4.
14. AXELRAD MA, KISILEVSKY R: Biological characterization of amyloid enhancing factor. In: GLENNER GG, COSTA PP, DE FREITAS AF (Eds): Amyloid and Amyloidosis. Proceedings of the Third International Symposium on Amyloidosis, Povoa de Varzim, Portugal 23-28 Sept. 1979. Amsterdam-Oxford-Princeton, Excerpta Medica, 1980: 527-33.
15. AXELRAD MA, KISILEVSKY R, WILLMER J, CHEN SJ, SKINNER M: Further characterization of amyloid-enhancing factor. Lab Invest 1982; 47: 139-46.
16. ABANKWA GV, ALI-KHAN Z: Alveolar hydatid cyst induced amyloid enhancing factor (AEF): physicochemical properties and abolition of AEF activity by serine protease inhibitors. Br J Exp Path 1988; 69: 133-48.
17. ERKEN E, SKINNER M, SHIRAHAMA T, JU S-T, COHEN AS: Identification and characterization of marine amyloid enhancing factor (AEF) from amyloidotic mouse spleen tissue extracts. Ann Med Sci 1993; 2: 12-7.
18. REID C, HEBERT L, POZZULO G, GERVAIS F: Splenic macrophage activation and functions in amyloid enhancing factor-induced secondary amyloidosis. Study of phagocytosis, killing, respiratory burst and MHC class II surface expression. J Leukoc Biol 1993; 53: 651-7.
19. SHIRAHAMA T, ABRAHAM CR, JU S-T, MIURA K, COHEN AS: Isolation of a 16 KD fraction with extremely high AEF activity. In: NATVIG JB, FØRRE Ø, HUSBY G, HUSEBEKK A, SKOGEN B, SLETTEN K, WESTERMARK P (Eds.): Amyloid and Amyloidosis 1990, Dordrecht, Boston & London, Kluwer Academic Publishers, 1990: 288-91.
20. KISILEVSKY R, NARINDRASORASAK S, TAPE C, TAN R, BOUDREAU L: During AA amyloidogenesis is proteolitic attack on serum amyloid A a pre- or a post-fibrillogenic event? Amyloid: IntJExp Clin Invest 1994; 1: 174-83.
21. COHEN AS: Clinical aspects of amyloidosis including related proteins and central nervous system amyloid. Curr Opin Rheumatol 1994; 6: 68-77.
22. GANOWIAK K, HULTMAN P, ENGSTROM U, GUSTAVSSON A, WESTERMARK P; Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. Biochem Biophys Res Commun 1994; 199: 306-12.
23. KEIZMAN I, RIMON A, SOHAR E, GAFNI J: Amyloid accelerating factor. Purification of a substance from human amyloidotic spleen that accelerates the formation of casein-induced murine amyloid. Acta Pathol Microbiol Scand 1972; 233 (Suppl.): 172-7.
24. YOKOTA T, ISHIHARA T, TAKAHASHI M, YAMASHITA Y, GONDO T, KAWAMURA S, HOSHII Y, KOGA M, IWATA T, UCHINO F: Isolation of amyloid enhancing factor (AEF). In: NATVIG JB, FØRRE Ø, HUSBY G, HUSEBEKK A, SKOGEN B, SLETTEN K, WESTERMARK P (Eds.): Amyloid and Amyloidosis 1990, Dordrecht, Boston & London, Kluwer Academic Publishers, 1990: 307-10.
25. CHRONOPOULOS S, LEMBO P, ALIZADEH-KHIAVI K, ALIKHAN Z: Ubiquitin: Its potential significance in murine AA amyloidogenesis. J Pathol 1992; 167: 249-59.
26. CHAN SL, LI W, CHRONOPOULOS S, ALIZADEH-KHIAVI K, ALI-KHAN Z: Characterization of murine AA amyloid-bound ubiquitin. In: KISILEVSKY R, BENSON MD, FRANGIONE B, GAULDIE J, MUCKLE TJ, YOUNG ID (Eds.): Amyloid and Amyloidosis 1993. New York & London. Parthenon Publishing, 1993: 520-2.
27. GERVAIS F, MORISSETTE C, FRANGIONE B: AEF extracted from brain of patients with Alzheimer's disease is associated with MBP. In: KISILEVSKY R, BENSON MD, FRANGIONE B, GAULDIE J, MUCKLE TJ, YOUNG ID (Eds.): Amyloid and Amyloidosis 1993, New York & London, Parthenon Publishing, 1993: 168-70.
28. NIEWOLD THA, GRUYS E, ARAKAWA T, SHIRAHAMA T, KISILEVSKY R: Recombinant human tumor necrosis factor-alpha (rhTNF-alpha) and rhTNF-alpha analogue enhance amyloid deposition in the Syrian hamster. Scand J Immunol 1993; 37: 29-32.
29. SHTRASBURG S, GAL R, PRAS M: Crush and smear technique for rapid detection and semiquantitation of amyloid deposition. Biotech Histochem 1991; 66: 203-7.
30. KISILEVSKY R, BENSON MD, AXELRAD MA, BOUDREAU L: The effect of a liver protein synthesis inhibitor on plasma SAA levels in a model of accelerated amyloid deposition. Lab Invest 1979; 41: 206-10.
31. PROPHET EB: Laboratory Methods in Histopathology. Washington D.C., American Registry of Pathology, 1992; 168.
32. PRELLI F, PRAS M, FRANGIONE B: The primary structure of human tissue amyloid P component from a patient with primary idiopathic amyloidosis. J Biol Chem 1985; 260: 12895-8.
33. KAPLAN B, PRAS M: Preparative fractionation of amyloid proteins on a microgram scale by high-performance liquid chromatography and polyacrylamide gel electrophoresis. Clin Chim Acta 1987; 163: 199-205.
34. LAEMMLI UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-2.
35. NIEWOLD THA, HOL PR, VAN ANDEL ACJ, LUTZ ETG, GRUYS E: Enhancement of amyloid induction by amyloid fibril fragments in hamster. Lab Invest 1987; 56: 544-9.
36. HAGER DA, BURGESS RR: Elution of proteins from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate, and renaturation of enzymatic activity: Results with sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase, and other enzymes. Anal Biochem 1980; 109: 76-86.
37. ROBERTS JD, CASERIO MC: Basic Principles of Organic Chemistry. New York & Amsterdam, W.A. Benjamin Inc, 1965; 449-53.
38. KEDAR (KEIZMAN) I, BLEIBERG I, SOHAR E: Stimulation of murine amyloidosis by a dializable product from pre-treated donors. Br J Exp Pathol 1975; 56: 244-6.
39. ALKARMI T, ALSHAKARCHI Z, BEHBEHAN K, ALI-KHAN Z: Echinococcus multilocularis: characterization of an alveolar hydatid cyst-induced amyloid enhancing factor. Br J Exp Pathol 1989; 70: 579-88.